vs

Side-by-side financial comparison of CURTISS WRIGHT CORP (CW) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

CURTISS WRIGHT CORP is the larger business by last-quarter revenue ($914.0M vs $665.5M, roughly 1.4× Natera, Inc.). CURTISS WRIGHT CORP runs the higher net margin — 14.0% vs 7.1%, a 6.9% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 13.4%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $-17.0M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 7.9%).

The Curtiss-Wright Corporation is an American manufacturer and services provider headquartered in Davidson, North Carolina, with factories and operations in and outside the United States. Created in 1929 from the consolidation of Curtiss, Wright, and various supplier companies, the company was immediately the country's largest aviation firm and built more than 142,000 aircraft engines for the U.S. military during World War II.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

CW vs NTRA — Head-to-Head

Bigger by revenue
CW
CW
1.4× larger
CW
$914.0M
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+26.4% gap
NTRA
39.8%
13.4%
CW
Higher net margin
CW
CW
6.9% more per $
CW
14.0%
7.1%
NTRA
More free cash flow
NTRA
NTRA
$54.8M more FCF
NTRA
$37.8M
$-17.0M
CW
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
7.9%
CW

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CW
CW
NTRA
NTRA
Revenue
$914.0M
$665.5M
Net Profit
$128.2M
$47.3M
Gross Margin
36.3%
Operating Margin
17.5%
-3.4%
Net Margin
14.0%
7.1%
Revenue YoY
13.4%
39.8%
Net Profit YoY
26.5%
187.9%
EPS (diluted)
$3.46
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CW
CW
NTRA
NTRA
Q1 26
$914.0M
Q4 25
$947.0M
$665.5M
Q3 25
$869.2M
$592.2M
Q2 25
$876.6M
$546.6M
Q1 25
$805.6M
$501.8M
Q4 24
$824.3M
$476.1M
Q3 24
$798.9M
$439.8M
Q2 24
$784.8M
$413.4M
Net Profit
CW
CW
NTRA
NTRA
Q1 26
$128.2M
Q4 25
$137.0M
$47.3M
Q3 25
$124.8M
$-87.5M
Q2 25
$121.1M
$-100.9M
Q1 25
$101.3M
$-66.9M
Q4 24
$117.9M
$-53.8M
Q3 24
$111.2M
$-31.6M
Q2 24
$99.5M
$-37.5M
Gross Margin
CW
CW
NTRA
NTRA
Q1 26
36.3%
Q4 25
37.5%
Q3 25
37.7%
Q2 25
37.2%
Q1 25
36.3%
Q4 24
38.5%
Q3 24
37.3%
Q2 24
36.2%
Operating Margin
CW
CW
NTRA
NTRA
Q1 26
17.5%
Q4 25
19.2%
-3.4%
Q3 25
19.1%
-16.5%
Q2 25
17.8%
-20.2%
Q1 25
16.0%
-15.8%
Q4 24
18.8%
-13.6%
Q3 24
18.1%
-8.9%
Q2 24
16.4%
-10.6%
Net Margin
CW
CW
NTRA
NTRA
Q1 26
14.0%
Q4 25
14.5%
7.1%
Q3 25
14.4%
-14.8%
Q2 25
13.8%
-18.5%
Q1 25
12.6%
-13.3%
Q4 24
14.3%
-11.3%
Q3 24
13.9%
-7.2%
Q2 24
12.7%
-9.1%
EPS (diluted)
CW
CW
NTRA
NTRA
Q1 26
$3.46
Q4 25
$3.69
$0.36
Q3 25
$3.31
$-0.64
Q2 25
$3.19
$-0.74
Q1 25
$2.68
$-0.50
Q4 24
$3.09
$-0.41
Q3 24
$2.89
$-0.26
Q2 24
$2.58
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CW
CW
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$343.4M
Total DebtLower is stronger
$757.6M
Stockholders' EquityBook value
$2.6B
$1.7B
Total Assets
$5.3B
$2.4B
Debt / EquityLower = less leverage
0.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CW
CW
NTRA
NTRA
Q1 26
$343.4M
Q4 25
Q3 25
$1.0M
Q2 25
$16.0M
Q1 25
$226.5M
$17.8M
Q4 24
$385.0M
$22.7M
Q3 24
$29.5M
Q2 24
$90.3M
Total Debt
CW
CW
NTRA
NTRA
Q1 26
$757.6M
Q4 25
$957.9M
Q3 25
$968.6M
Q2 25
$958.4M
Q1 25
$958.6M
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Stockholders' Equity
CW
CW
NTRA
NTRA
Q1 26
$2.6B
Q4 25
$2.5B
$1.7B
Q3 25
$2.5B
$1.3B
Q2 25
$2.7B
$1.2B
Q1 25
$2.6B
$1.2B
Q4 24
$2.4B
$1.2B
Q3 24
$2.5B
$878.5M
Q2 24
$2.5B
$836.5M
Total Assets
CW
CW
NTRA
NTRA
Q1 26
$5.3B
Q4 25
$5.2B
$2.4B
Q3 25
$5.1B
$1.8B
Q2 25
$5.2B
$1.8B
Q1 25
$5.0B
$1.7B
Q4 24
$5.0B
$1.7B
Q3 24
$4.9B
$1.6B
Q2 24
$4.7B
$1.5B
Debt / Equity
CW
CW
NTRA
NTRA
Q1 26
0.29×
Q4 25
0.38×
Q3 25
0.38×
Q2 25
0.35×
Q1 25
0.37×
Q4 24
0.43×
Q3 24
0.42×
Q2 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CW
CW
NTRA
NTRA
Operating Cash FlowLast quarter
$73.9M
Free Cash FlowOCF − Capex
$-17.0M
$37.8M
FCF MarginFCF / Revenue
-1.9%
5.7%
Capex IntensityCapex / Revenue
1.3%
5.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$591.2M
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CW
CW
NTRA
NTRA
Q1 26
Q4 25
$352.7M
$73.9M
Q3 25
$192.8M
$59.4M
Q2 25
$136.6M
$37.6M
Q1 25
$-38.8M
$44.5M
Q4 24
$301.3M
$52.9M
Q3 24
$177.3M
$51.8M
Q2 24
$111.3M
$4.0M
Free Cash Flow
CW
CW
NTRA
NTRA
Q1 26
$-17.0M
Q4 25
$315.1M
$37.8M
Q3 25
$175.9M
$37.0M
Q2 25
$117.2M
$11.7M
Q1 25
$-54.5M
$22.6M
Q4 24
$278.0M
$34.8M
Q3 24
$162.7M
$35.5M
Q2 24
$100.3M
$-7.7M
FCF Margin
CW
CW
NTRA
NTRA
Q1 26
-1.9%
Q4 25
33.3%
5.7%
Q3 25
20.2%
6.2%
Q2 25
13.4%
2.1%
Q1 25
-6.8%
4.5%
Q4 24
33.7%
7.3%
Q3 24
20.4%
8.1%
Q2 24
12.8%
-1.9%
Capex Intensity
CW
CW
NTRA
NTRA
Q1 26
1.3%
Q4 25
4.0%
5.4%
Q3 25
1.9%
3.8%
Q2 25
2.2%
4.7%
Q1 25
2.0%
4.3%
Q4 24
2.8%
3.8%
Q3 24
1.8%
3.7%
Q2 24
1.4%
2.8%
Cash Conversion
CW
CW
NTRA
NTRA
Q1 26
Q4 25
2.57×
1.56×
Q3 25
1.54×
Q2 25
1.13×
Q1 25
-0.38×
Q4 24
2.56×
Q3 24
1.59×
Q2 24
1.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons